Strong Q3 2013 revenue growth of 43%

Fluidigm to Announce Q3 2013 Financial Results and Host Conference Call for Investors

Fluidigm and Nanostring Agree to Litigation Settlement
NanoString to Refrain From Using Single-Cell Comparison Study Marketing Materials

Fluidigm C1 Single-Cell Auto Prep System Wins Prestigious IBO Design Award
Recognized for Excellence in Analytical Instrument Industrial Design

Fluidigm Reports Strong Q2 2013 Revenue Growth Of 35%
Record Instrument Revenue Driven by Rapidly Growing Single-Cell Genomics Market

Fluidigm Enables the Study of miRNA Master Regulators Down to the Single Cell Level
C1TM System Provides Simplest, Most Sensitive Method to Investigate Gene Regulation

Fluidigm and Olink Bioscience Bring a New Level of Protein Biomarker Discovery to the Market

Fluidigm to Announce Q2 2013 Financial Results and Host Conference Call for Investors

Rapid Detection of Pathogens Will Help Control Threats such as Flu Pandemic and SARS
Rapid Detection of Pathogens by the Fluidigm System Will Help Control Serious Threats to Public Health such as Flu Pandemics and SARS.

Fluidigm to Present at the Bank Of America Merrill Lynch 2013 Health Care Conference